{
  "id": 9754722,
  "title": "Alnylam alumni-led RNAi biotech City Therapeutics files for IPO",
  "url": "https://urgent.news/2026/09/25/alnylam-alumni-led-rnai-biotech-city-therapeutics-files-for-ipo",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-25T11:04:51.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/alnylam-alumni-led-rnai-biotech-city-therapeutics-files-for-ipo/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Biotechs are rushing into the IPO queue. City Therapeutics submitted its public pitch late Thursday, the same night ADARx Pharmaceuticals priced its $446 million Nasdaq debut. Kendall Square-based ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "City Therapeutics files for US IPO as biotech listings surge",
        "url": "https://urgent.news/2026/09/24/city-therapeutics-files-for-us-ipo-as-biotech-listings-surge",
        "published": "2026-09-24T22:30:51.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}